Literature DB >> 15734487

Effects of progesterone and estrogen on endothelial dysfunction in porcine coronary arteries.

Mitchell W Cox1, Weiping Fu, Hong Chai, Ramesh Paladugu, Peter H Lin, Alan B Lumsden, Qizhi Yao, Changyi Chen.   

Abstract

BACKGROUND: The effects of hormone replacement therapy (HRT) on the vascular endothelium have been controversial. In this study, we determined the effects of HRT on endothelium-dependent relaxation in a porcine coronary artery model.
METHODS: Coronary artery rings harvested from female swine were incubated as controls or with estrogen (10(-9), 10(-8), 10(-7) g/L), progesterone (1 x 10(-6), 1 x 10(-5), 5 x 10(-5) g/L), or a combination of the two (10(-8)g/L estrogen, 1 x 10(-5)g/L progesterone). After 24 h in tissue culture, the rings were tested on a myograph system to measure contraction and endothelium-dependent relaxation. Myograph analysis was performed with the thromboxane A2 analogue U46619 for contraction and bradykinin or sodium nitroprusside for relaxation. Nitric oxide synthase (eNOS) levels were determined by immunohistochemistry. Levels of superoxide anion in the progesterone or estrogen treated tissues were assessed by lucigenin-enhanced chemiluminescence analysis.
RESULTS: In response to 10(-7)M bradykinin, porcine coronary artery rings treated with 1 x 10(-6), 1 x 10(-5) and 5 x 10(-5) g/L of progesterone showed a significant reduction in endothelium-dependent vasorelaxation by 36%, 45%, and 68%, respectively, as compared to controls (P <0.05). However, rings treated with estrogen showed no significant difference as compared to controls. Furthermore, estrogen treatment with progesterone reversed the effect of progesterone, showing no difference in vessel relaxation as compared to controls. There were no differences in endothelium-independent vasorelaxation (sodium nitroprusside) or in smooth muscle contractility (U46619) between the control and the hormone-treated groups. The eNOS immunoreactivity was reduced in progesterone-treated coronary artery rings. Furthermore, coronary endothelium exposed to progesterone showed a 59% increase in superoxide anion production, while estrogen produced a 67% decrease when compared to controls (P <0.05 for both).
CONCLUSION: This data suggests that the progesterone component of HRT has a detrimental influence on endothelium-dependent relaxation. This effect appears to be related to decreased eNOS levels, as well as increased consumption of NO by superoxide anion in the endothelium of tissues exposed to progesterone. Estrogen can block progesterone-induced endothelial dysfunction and superoxide anion production in the pig coronary artery model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734487     DOI: 10.1016/j.jss.2004.09.003

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  13 in total

Review 1.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

Review 2.  Role of pregnancy hormones and hormonal interaction on the maternal cardiovascular system: a literature review.

Authors:  Vitaris Kodogo; Feriel Azibani; Karen Sliwa
Journal:  Clin Res Cardiol       Date:  2019-02-26       Impact factor: 5.460

Review 3.  Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.

Authors:  Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-01

Review 4.  Hormonal modulation of endothelial NO production.

Authors:  Sue P Duckles; Virginia M Miller
Journal:  Pflugers Arch       Date:  2010-03-07       Impact factor: 3.657

Review 5.  Vascular effects of estrogenic menopausal hormone therapy.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Rev Recent Clin Trials       Date:  2012-02

Review 6.  Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.

Authors:  Kirtiman Srivastava; Philip M W Bath; Ulvi Bayraktutan
Journal:  Cell Mol Neurobiol       Date:  2011-12-25       Impact factor: 5.046

7.  17β-estradiol and progesterone independently augment cutaneous thermal hyperemia but not reactive hyperemia.

Authors:  Vienna E Brunt; Jennifer A Miner; Jessica R Meendering; Paul F Kaplan; Christopher T Minson
Journal:  Microcirculation       Date:  2011-07       Impact factor: 2.628

8.  Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.

Authors:  Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2013-10-04       Impact factor: 5.858

Review 9.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Influence of progesterone on endometrial nitric oxide synthase expression.

Authors:  Omid Khorram; Guang Han
Journal:  Fertil Steril       Date:  2008-08-16       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.